1. Home
  2. UPLD vs EVAX Comparison

UPLD vs EVAX Comparison

Compare UPLD & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$0.71

Market Cap

28.4M

Sector

Technology

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.80

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
EVAX
Founded
2010
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
31.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
UPLD
EVAX
Price
$0.71
$3.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.75
$11.67
AVG Volume (30 Days)
374.8K
32.1K
Earning Date
03-03-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$1.20
52 Week High
$3.90
$12.15

Technical Indicators

Market Signals
Indicator
UPLD
EVAX
Relative Strength Index (RSI) 44.52 55.05
Support Level $0.51 $2.45
Resistance Level $1.62 $4.64
Average True Range (ATR) 0.07 0.39
MACD 0.02 0.07
Stochastic Oscillator 68.98 54.62

Price Performance

Historical Comparison
UPLD
EVAX

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: